Organization Logo

RESTRICTIVE MITRAL VALVE ANNULOPLASTY

J. Braun

 

Leiden, The Netherlands

Introduction : Mitral regurgitation (MR) resulting from ischemia and / or dilated cardiomyopathy carries a poor prognosis if not properly treated. We hypothesized that restrictive (undersized) annuloplasty cures MR which improves left ventricular function and patients' functional status.

Methods : Between January 2000 and January 2002, 35 patients underwent restrictive mitral annuloplasty (RMA). Twenty-seven patients had posterior wall ischemia (PWI) and were scheduled for CABG, 8 patients had dilating cardiomyopathy (DCMP). Mean age was 65 years (range: 33 - 77 years). All patients underwent undersized (i.e. two ring sizes) mitral annuloplasty: mean annulus: 31.4 mm, mean ring: 27.5 mm. In the ischemic group all patients underwent CABG (mean 2.5 anastomoses). Additional tricuspid valvuloplasty was performed in six patients.

Results : In-hospital mortality for the ischemic group was 3 out of 27; for the DCMP group it was 1 out of 8. Mean duration of follow-up was 13 months. There were two late deaths (one in each group).

Echocardiographic results at a follow-up of 8 months:

 
All patients
 
PWI
 
DCMP
 
 
Pre-op
Current
Pre-op
Current
Pre-op
Current
Mean
NYHA
3.3
1.2
3.3
1.2
3.5
1.0
LVEDD
(mm)
62
58
60
56
78
74

Mean MR
grade

3.3
0.4
3.3
0.4
3.5
0.


LVEDD : left ventricular end-diastolic dimension

Conclusion : RMA treats MR with equal success in dilated cardiomyopathy and in ischemia. At mid-term follow-up, LV diameter decreases, freedom from MR persists and functional status improves.

Organization Logo
Last Modified: 2-Aug-2005
Copyright and Disclaimer